HIV Entry Inhibitors Targeting gp41: From Polypeptides to Small-Molecule Compounds

E-ISSN： 1873-4286|13|2|143-162

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.2, 2007-01, pp. : 143-162

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of Small-molecule HIV Entry Inhibitors Specifically Targeting gp120 or gp41

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 10, 2016-04 ,pp. : 1074-1090

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery of Small Molecule Fusion Inhibitors Targeting HIV-1 gp41

Current Pharmaceutical Design, Vol. 19, Iss. 10, 2013-03 ,pp. : 1818-1826

Bentham Science Publishers

Access to resources Recommend Favorite

High Throughput Screening and Characterization of HIV-1 Entry Inhibitors Targeting gp41: Theories and Techniques

Current Pharmaceutical Design, Vol. 10, Iss. 15, 2004-06 ,pp. : 1827-1843

Bentham Science Publishers

Access to resources Recommend Favorite

Development for Anticancer Therapy: Small-Molecule Inhibitors Targeting Protein Kinase B

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 9, 2013-01 ,pp. : 1272-1294

Bentham Science Publishers

Access to resources Recommend Favorite

Perspectives on Developing Small Molecule Inhibitors Targeting HIV-1 Integrase

Mini Reviews in Medicinal Chemistry, Vol. 12, Iss. 9, 2012-08 ,pp. : 875-889

Bentham Science Publishers

Access to resources Recommend Favorite